伴有辅酶Q10缺乏的小脑共济失调:辅酶Q10补充后的诊断与随访

Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation.

作者信息

Artuch Rafael, Brea-Calvo Gloria, Briones Paz, Aracil Asunción, Galván Marta, Espinós Carmen, Corral Jordi, Volpini Victor, Ribes Antonia, Andreu Antoni L, Palau Francesc, Sánchez-Alcázar José A, Navas Plácido, Pineda Mercè

机构信息

Biochemistry Department, Hospital Sant Joan de Déu, Barcelona, Spain.

出版信息

J Neurol Sci. 2006 Jul 15;246(1-2):153-8. doi: 10.1016/j.jns.2006.01.021. Epub 2006 May 3.

Abstract

UNLABELLED

Our aim was to report a new case with cerebellar ataxia associated with coenzyme Q10 (CoQ) deficiency, the biochemical findings caused by this deficiency and the response to CoQ supplementation.

PATIENT

A 12-year-old girl presenting ataxia and cerebellar atrophy. BIOCHEMICAL STUDIES: Coenzyme Q10 in muscle was analysed by HPLC with electrochemical detection and mitochondrial respiratory chain (MRC) enzyme activities by spectrophotometric methods. CoQ biosynthesis in fibroblasts was assayed by studying the incorporation of radiolabeled 4-hydroxy[U 14C] benzoic acid by HPLC with radiometric detection.

RESULTS

Mitochondrial respiratory chain enzyme analysis showed a decrease in complex I + III and complex II + III activities. CoQ concentration in muscle was decreased (56 nmol/g of protein: reference values: 157-488 nmol/g protein). A reduced incorporation of radiolabeled 4-hydroxy[U- 14C] benzoic acid was observed in the patient (19% of incorporation respect to the median control values). After 16 months of CoQ supplementation, the patient is now able to walk unaided and cerebellar signs have disappeared.

CONCLUSIONS

Cerebellar ataxia associated with CoQ deficiency in our case might be allocated in the transprenylation pathway or in the metabolic steps after condensation of 4-hydroxybenzoate and the prenyl side chain of CoQ. Clinical improvement after CoQ supplementation was remarkable, supporting the importance of an early diagnosis of this kind of disorders.

摘要

未标注

我们的目的是报告一例与辅酶Q10(CoQ)缺乏相关的小脑共济失调新病例、这种缺乏所导致的生化发现以及对辅酶Q补充的反应。

患者

一名12岁女孩,表现为共济失调和小脑萎缩。

生化研究

采用高效液相色谱电化学检测法分析肌肉中的辅酶Q10,采用分光光度法分析线粒体呼吸链(MRC)酶活性。通过研究放射性标记的4-羟基[U 14C]苯甲酸的掺入情况,采用高效液相色谱放射性检测法测定成纤维细胞中的辅酶Q生物合成。

结果

线粒体呼吸链酶分析显示复合体I + III和复合体II + III活性降低。肌肉中的辅酶Q浓度降低(56 nmol/g蛋白质:参考值:157 - 488 nmol/g蛋白质)。在患者中观察到放射性标记的4-羟基[U - 14C]苯甲酸的掺入减少(相对于中位对照值的掺入率为19%)。补充辅酶Q 16个月后,患者现在能够独立行走,小脑体征已消失。

结论

在我们的病例中,与辅酶Q缺乏相关的小脑共济失调可能发生在异戊二烯基化途径或4-羟基苯甲酸与辅酶Q的异戊烯侧链缩合后的代谢步骤中。补充辅酶Q后临床改善显著,支持了早期诊断这类疾病的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索